Diligence memo · auto-generated · as of July 3, 2026
Reprieve Cardiovascular, Inc.
Reprieve Cardiovascular, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Reprieve Cardiovascular, Inc. operates in Other Health Care, based in Milford.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Reprieve Cardiovascular, Inc. has raised $82M in disclosed capital across 5 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $31M on 2025-05-28.
Most recent recorded round closed around 2025-05-28.
Valuation (modeled)modeled
Provath models Reprieve Cardiovascular, Inc. at approximately $153M (range $73M–$230M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.66× the median modeled value of Series B Other Health Care companies in 2025–2027 (48 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 13 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 6.2× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 95% of Other Health Care peers (5377 compared).
Modeled value ranks above 85% of those peers.
Closest niche peers: Imagine Pediatrics Holdings LLC, Porter Cares, Inc., True Medicine Inc., CranioVation, Inc., Seriously Clean LTD..
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.